Skip to main content
. 2021 May 21;100(20):e26040. doi: 10.1097/MD.0000000000026040

Figure 3.

Figure 3

Kaplan–Meier and ROC analyses of sarcoma patients with different ages (A and B), genders (C and D), histological subtypes (E and F), anatomic locations (G and H), and residual disease R classifications (I and J). Kaplan–Meier estimates of the patients’ OS and ROC curves show the sensitivity and specificity of the 3-DNA methylation signature in predicting the patients’ OS. OS = overall survival, ROC = receiver operating characteristic.